Importantly, increased sensome activity is driven by a limited set of specific genes (Cd74, Clec7a, Cxcl16), while key homeostatic genes responsible for general sensing changes in the brain are downregulated, confirming the reduced capacity to sense changes in the TME caused by GBM. The gene discussed is CD74; the disease is glioblastoma.